Online Program Home
My Program

Abstract Details

Activity Number: 388
Type: Roundtables
Date/Time: Tuesday, August 2, 2016 : 12:30 PM to 1:50 PM
Sponsor: Biopharmaceutical Section
Abstract #320691
Title: Statistical Issues in the Design and Analysis of Rheumatology Trials
Author(s): Yongman Kim*
Companies: FDA
Keywords:
Abstract:

Statistical issues in trials in rheumatology conditions such as rheumatoid arthritis (RA) and psoriatic arthritis (PsA) will be discussed within the purview of clinical development of drug products. Impacts of design features on statistics-including patient population, control group, background treatment, rescue, or escape treatment-and key efficacy endpoints will be discussed. In addition, we will discuss statistical methods such as defining the estimand (e.g., ITT or de facto), handling escape and/or missing data, sensitivity analyses, analytic models, multiplicity adjustment for secondary endpoints proposed for inclusion in the product label, etc. Also, we will briefly discuss features of analysis-ready data sets (ADaM) relating to recent work of the RA therapeutic area user guide (TAUG) group of CFAST.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association